METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could fewer treatments keep advanced prostate cancer in check?
Disease control Not yet recruitingThis study is testing a new approach for giving a targeted radiation drug to men with advanced prostate cancer that has stopped responding to hormone therapy. It will compare the standard schedule of six doses given every six weeks to a new approach where, after two successful do…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
First-in-Human trial launches for promising new prostate cancer pill
Disease control Not yet recruitingThis is the first study in people to test the safety of a new oral drug called (R)-9bMS for advanced prostate cancer that has spread and stopped responding to standard hormone therapies. The main goal is to find a safe dose and see how well patients tolerate the medication. About…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: TechnoGenesys, Inc. • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC